Nectar Lifesciences Ltd.

NECLIFE Share PricePharmaceuticals & Drugs

21.04

0.1 (0.5%)

As on December 12, 2025

Exchange Scrips: BSE532649NSENECLIFEISININE023H01027

Market Cap475 Cr

P/E Ratio -4.15

Dividend Yield N/A

Performance

Market performance

Open21
High21.2
Volumes16,58,377
Prev21.04
Low20.94
As on2025-12-12

Historical performance

1 Year High44.41
3 Year High56.5
5 Year High56.5
1 Year Low13.05
3 Year Low13.05
5 Year Low13.05

Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
475
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
-4.15
Dividend Yield
Dividend Yield
N/A

Investment Returns

1 Year
-43%
3 Years
-9.9%
5 Years
4.2%
10 Years
-61%

Technicals

IndicatorsValueSignal
5-DMA20.87Bullish
10-DMA20.01Bullish
20-DMA17.34Bullish
50-DMA15.52Bullish
100-DMA15.46Bullish
200-DMA19.45Bullish

Shareholding Pattern

FieldSep-2025Jun-2025Mar-2025Dec-2024Sep-2024
Promoters33332
Foreign Investors---------------
Domestic Investors33332
Public Investors7646771974692386947966738
Government11111

Financials

Below figures are in Rs. Crores

Balance Sheet

Below figures are in Rs. Crores

Cash Flow

Below figures are in Rs. Crores

0%
Negative
Neutral
Positive
  • The stock has a PE ratio of -4.15.
  • 3Y Stock Price CAGR of the stock is -3.4.
  • The stock has a beta of 1.1.
  • In the last financial year, the company had an EBITDA of ₹-221 Million.
  • The company generated revenue of ₹16700 Million in the previous financial year.

Nectar Lifesciences Ltd.

21.040.1   (0.5%)

Investment Amount: ₹ 1000000
Current Value: ₹ 517461.9
No. of Shares: 24594 (Approx)
Performance:-48.3%
P/L: ₹-482538.1

Top Gainers

SymbolChange%
MAHAPEXLTD95.24(20%)
VIPULLTD10.24(20%)
TVVISION7.77(20%)
TARIL280.2(17%)
WALCHANNAG175.53(14%)

Top Losers

SymbolChange%
REFEX254.9(-20%)
VLSFINANCE299.45(-10%)
BALAXI30.06(-9%)
VLEGOV21.01(-9%)
KSR17.33(-9%)
ASMS12.2(-8%)
VINNY1.28(-7%)
RAJSREESUG37.79(-6%)

Peer Comparison

Venus Remedies Ltd.

53.5%

825.4

1 Month Performance

SMS Pharmaceuticals Ltd.

11.4%

320.7

1 Month Performance

Natco Pharma Ltd.

10.1%

905.65

1 Month Performance

Haleos Labs Ltd.

9.8%

1386.8

1 Month Performance

Ipca Laboratories Ltd.

9.3%

1465.9

1 Month Performance

Zota Health Care Ltd.

9%

1670.2

1 Month Performance

Emcure Pharmaceuticals Ltd.

7.6%

1438.6

1 Month Performance

Glenmark Pharmaceuticals Ltd.

6.9%

1975

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month